Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.44), Zacks reports. Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%.
Bioceres Crop Solutions Trading Up 2.2%
NASDAQ:BIOX traded up $0.01 during trading hours on Monday, hitting $0.43. The company had a trading volume of 275,527 shares, compared to its average volume of 524,470. The stock has a 50-day moving average price of $0.38 and a 200 day moving average price of $0.44. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70. The company has a market capitalization of $27.07 million, a PE ratio of -0.11 and a beta of 0.44. Bioceres Crop Solutions has a 52 week low of $0.30 and a 52 week high of $2.19.
Wall Street Analyst Weigh In
Separately, Weiss Ratings cut Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Monday, July 13th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $2.00.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Recommended Stories
- Five stocks we like better than Bioceres Crop Solutions
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
